No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $59 to $67
Ionis Pharmaceuticals' Growth Prospects Bolstered by FDA Approval of Tryngolza
Sector Update: Health Care Stocks Mixed Premarket Friday
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
Needham Maintains Buy on Ionis Pharmaceuticals, Maintains $60 Price Target
Ionis Pharmaceuticals Analyst Ratings